Wikipedia -WSS

Wikipedia

author：hotspot 2025-10-01 04:32:49 - browse：5128

Photograph of a person wearing blue gloves counts money. -- health business coverage from STAT — Adobe

WASHINGTON — Doctors are staring down a cut to their Medicare pay next year, and while the news has united them in outrage, it’s also turned one specialty against another.

Medicare officials last week announced its major annual update to the way the program pays physicians. Along with other changes, it includes a policy that will boost payments to specialties that rely on evaluating and managing patients, as opposed to those that focus on procedures. But in Medicare, boosting payments in one area almost always means cutting them somewhere else. So to pay for that, doctors across the country will see a roughly 3% cut to a factor that determines how much Medicare pays them for caring for seniors.

The change has pitted certain specialties against primary care doctors. A host of surgeons’ groups, including the American College of Surgeons, plainly criticized family physicians in a recent letter to Medicare, saying there’s no “valid justification” for the boost and calling it an “inappropriate” overpayment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Why Novartis is going to walk from its acquisition of MorphoSys

knowledge

WSS

The United States must get value

The CDC's new social media misinformation war

Updated Covid vaccine has 54% effectiveness, new study suggests

Updated Covid vaccine has 54% effectiveness, new study suggests

What’s missing from the debate over nursing home staff minimums

AI gets buy

hotspot

Wikipedia

entertainment

Psychedelics group wrestles with new pharma identity

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why Novartis is going to walk from its acquisition of MorphoSys

Moonlake's readout produced a cash windfall. Risks remain

Medicare Advantage plans can’t deny care with AI, CMS warns

Jerome Adams on the need for new antivirals for Covid

Problems with a popular proposal to regulate AI in health care

Drug repurposing or repositioning? The language matters

CVS is willing to dump 10% of its Medicare Advantage members

hotspot

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

AI gets buy

Global cancer cases to surge 77% by 2050, WHO report says

Fertility clinic egg and embryo storage is a disaster

Texas Medical Board asked to define abortion emergency exception

Johnson & Johnson sued for allegedly overpaying for workers' drugs

explore

knowledge

knowledge

explore